Eli Lilly & Co (NYSE:LLY). experienced a decrease in share value for the second consecutive day, with a 3.42% drop on Thursday, closing at $550.13. This downturn is part of a broader decline...
- Day's Range
- 156.22 - 157.96
- 52 wk Range
- 150.11 - 181.04
- Prev. Close
- Average Vol.(3m)
- 1-Year Change
- Market Cap
- P/E Ratio
- United States
- Shares Outstanding
- Dividend (Yield)
- 4.76 (3.03%)
- Next Earnings Date
- Oct 17, 2023
On Tuesday, IDEXX Laboratories Inc. (NASDAQ:IDXX) shares closed at $457.38, marking a 1.58% increase, breaking the company's two-day losing streak. This rise came in contrast to the broader...
An analyst from Leerink Partners maintained J&J (NYSE: JNJ) at 'outperform' with a price target of $182.00 from a prior price target of %currency%%price%. Prior to this rating, J&J...
Berkshire Hathaway (NYSE:BRKa), led by CEO Warren Buffett, continues to see significant gains from its investment strategy focusing on profitable, brand-name businesses. The company is set...
An analyst from Barclays maintained J&J (NYSE: JNJ) at 'equalweight' with a price target of $158.00 from a prior price target of %currency%%price%. Prior to this rating, J&J had 8...
HSBC initiated coverage of 11 U.S. biopharmaceutical and healthcare stocks in a note to clients on Wednesday. Analysts assigned Actinium Pharmaceuticals Inc (NYSE:ATNM), Amgen (NASDAQ:AMGN),...
An analyst from HSBC initiated coverage of J&J (NYSE: JNJ) at 'hold' with a price target of $175.00. Prior to this rating, J&J had 8 buy ratings, 13 hold ratings, and 1 sell...
An analyst from Morgan Stanley maintained J&J (NYSE: JNJ) at 'equalweight' with a price target of $172.00 from a prior price target of %currency%%price%. Prior to this rating, J&J...
An analyst from Wells Fargo maintained J&J (NYSE: JNJ) at 'overweight' with a price target of $186.00 from a prior price target of %currency%%price%. Prior to this rating, J&J had...
Investing.com -- U.S. futures traded with small losses Wednesday, handing back some of the recent gains ahead of the release of more important labor market economic data. Here are some of...
Johnson & Johnson (NYSE:JNJ) has made updates to its financials and 2023 guidance after the completion of the Kenvue (NYSE:KVUE) separation. “The completion of this transaction uniquely...
The Biden administration has today taken a significant step towards addressing the affordability of prescription drugs for older Americans. Recent changes to the Medicare bill allow Medicare...
Investing.com -- Shares in 3M Co. (NYSE:MMM) climbed in premarket U.S. trading on Monday following media reports that the industrial conglomerate has tentatively agreed to pay over $5.5...
Johnson & Johnson (NYSE:JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of...
Kenvue Inc. (KVUE) will replace Advance Auto Parts Inc. (NYSE:AAP) in the S&P 500, and Advance Auto Parts will replace Emergent BioSolutions Inc. (EBS) in the S&P SmallCap 600 effective...
Investing.com -- Shares in Johnson & Johnson (NYSE:JNJ) slipped on Monday after the American healthcare giant said it will retain about a 9.5% stake in its consumer health carve-out Kenvue...
Warren Buffett's Berkshire Hathaway released its 13F for the quarter ended June 30, 2023. Below is a summary:New Stakes D. R. Horton (DHI) new 5,969,714 share position Lennar Corp....
Investing.com -- U.S. stocks were rising after July's report on the consumer price index came in cooler than expected, stoking hopes the Federal Reserve can hold steady on interest rates...
Investing.com -- U.S. futures rose Thursday, with investors awaiting a key inflation release which could provide clues towards future Federal Reserve interest rate decisions. Here are some...
Investing.com -- The Dow closed higher Monday to wrap up a second-straight positive month for July after shrugging off a dip in health care as energy stocks racked up gains. The Dow Jones...
Investing.com -- The S&P 500 was largely unchanged Monday as falling health care stocks capped upside momentum on the final day of trade in July ahead of another wave of earnings this...
Investing.com -- U.S. stocks were edging higher on Monday as a deluge of earnings from tech giants and other megacap companies are expected this week. Here are some of the biggest U.S. stock...
Johnson & Johnson (NYSE:JNJ) declined after its latest attempt to resolve tens of thousands of lawsuits over baby powder and talc products through bankruptcy of a unit was dismissed by a...
Investing.com -- U.S. futures edged higher Monday, at the start of a week that includes more earnings from tech giants as well as the important monthly jobs report. Here are some of the...
An analyst from Barclays maintained J&J (NYSE: JNJ) at 'equalweight' with a price target of $175.00 from a prior price target of %currency%%price%. Prior to this rating, J&J had 8...
Investing.com -- U.S. stocks were rising on Monday as investors soaked in more corporate earnings ahead of this week's Federal Reserve meeting. Here are some of the biggest U.S. stock movers...
On Monday, Johnson & Johnson (NYSE:JNJ) announced an exchange offer for its stockholders to choose shares of Kenvue (NYSE:KVUE), its newly listed consumer health unit. The company said it...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.